Toxoplasmosis, a prevalent widespread infection in man and animals, is mainly transmitted by oral route, through ingestion of oocysts from water and food contaminated with cat feces or infected animal tissue cysts in undercooked meat. Vaccine development implies in effective intestinal immunity, the first site of parasite entry. Radiation (255Gy/ 60 Co) sterilized T. gondii RH strain tachyzoites (RST) induced significant protection when parentally administered, similar to chronically infected and acute disease protected animal. We study the humoral immune response in C57Bl/6j and BALB/c mice immunized with 10 7 RST, by oral (with aluminium hydroxide 3%) or parenteral 3 biweekly administrations. T. gondii antigens specific ELISA for IgG, IgA, IgG1, IgG2a and IgG2b detection was performed in weekly blood samples during immunization. Also we evaluate of the intestinal epithelial of immunized mice the integrity of the radiated parasites by electronic microscopy. After 2 weeks, immunized and control animals were challenged with 10 cysts of ME-49 strain p.o. Protection was determined at the 30 th day by brain cyst counting. As it was possible to observe in the intestinal mucosal, the aluminium hydroxide seems to maintain unchanged the parasite morphology and its mechanisms of invasion, probably due to keeping it safe from extreme pH condition of stomach. All immunized groups presented significant protection when challenged with ME-49; however, BALB/c mice showed better protection levels, with only one positive animal on brain microscopic analysis. IgG production in the serum of the animals was higher in groups immunized by i.p route, however, IgA and IgG1 levels were higher in BALB/c mice immunized by oral route. This higher protection found in BALB/c group could probably also be related to the Th2 response, demonstrated by higher IgG1 levels. All these data provide insights in oral immunization schedules for toxoplasmosis prevention, suggesting that oral vaccines could be an alternative in the prevention of toxoplasmosis and the block of chain transmission.
[1]
Y. Sukthana.
Toxoplasmosis: beyond animals to humans.
,
2006,
Trends in parasitology.
[2]
R. Larocque,et al.
Oral Immunization of BALB/c Mice with Giardia duodenalis Recombinant Cyst Wall Protein Inhibits Shedding of Cysts
,
2003,
Infection and Immunity.
[3]
H. F. de Andrade,et al.
200 Gy sterilised Toxoplasma gondii tachyzoites maintain metabolic functions and mammalian cell invasion, eliciting cellular immunity and cytokine response similar to natural infection in mice.
,
2002,
Vaccine.
[4]
E. van Garderen,et al.
IgA and the IgA Fc receptor.
,
2001,
Trends in immunology.
[5]
A. Cripps,et al.
Vaccines and mucosal immunisation.
,
2001,
Vaccine.
[6]
E. James,et al.
Cryopreservation of an attenuated vaccine strain of the protozoan parasite Toxoplasma gondii.
,
1996,
Cryobiology.
[7]
C. Hsieh,et al.
T cell genetic background determines default T helper phenotype development in vitro
,
1995,
The Journal of experimental medicine.
[8]
D. Wakelin,et al.
ELISAs for parasitologists: or lies, damned lies and ELISAs.
,
1993,
Parasitology today.
[9]
C. Corbett,et al.
A fast method for processing biologic material for electron microscopic diagnosis in infectious disease.
,
1992,
Ultrastructural pathology.
[10]
D. Buxton.
Toxoplasmosis: the first commercial vaccine.
,
1993,
Parasitology today.